On March 2, 2022 Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer will present a corporate overview at Raymond James Institutional Investors Conference, being held in Orlando on March 6-9, 2022 (Press release, Leap Therapeutics, MAR 2, 2022, View Sourcenews-releases/news-release-details/leap-therapeutics-present-raymond-james-43rd-annual" target="_blank" title="View Sourcenews-releases/news-release-details/leap-therapeutics-present-raymond-james-43rd-annual" rel="nofollow">View Source [SID1234609398]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leap Presentation Details:

Raymond James Annual Institutional Investors Conference
Date: Wednesday, March 9th, 2022
Time: 7:30 a.m. Eastern Time

The presentation will be webcast live and may be accessed on the Investors page of the company’s website at View Source, where a replay of the event will also be available for a limited time.